Survey of the rate of PSA testing in general practice

J Melia; S Moss

doi:10.1054/bjoc.2001.1962

Survey of the rate of PSA testing in general practice

Br J Cancer. 2001 Sep 1;85(5):656-7. doi: 10.1054/bjoc.2001.1962.

Authors

J Melia¹, S Moss

Affiliation

¹ Cancer Screening Evaluation Unit, Institute of Cancer Research, Section of Epidemiology, D Block, Cotswold Road, Sutton, Surrey, SM2 5NG, UK.

Abstract

The use of prostate specific antigen (PSA) test could have a large impact on the incidence of prostate cancer in the UK. Over a period of 1 year (1999), 3.5% out of 160 015 men aged > 45 on a GP database, who had no previous record of prostate cancer, had a PSA test. Of the tested men, 21.3% had a PSA > 4 ng/ml. Future data need to distinguish between men with and without symptoms.

Publication types

Research Support, Non-U.S. Gov't

MeSH terms

Age Distribution
Aged
Family Practice / statistics & numerical data
Health Care Surveys / statistics & numerical data
Humans
Male
Middle Aged
Prostate-Specific Antigen / analysis*
Retrospective Studies

Substances

Prostate-Specific Antigen